GoPro, Inc. (NASDAQ:GPRO) said it has appointed Zander Lurie — formerly a senior exec with Guggenheim Digital Media and CBS — as senior VP of media. GoPro, Inc. (NASDAQ:GPRO)'s stock on 04 November traded at beginning with a price of $85.00 and when day-trade ended the stock finally moved down -2.43% to end at $82.27. GoPro, Inc. (NASDAQ:GPRO)'s showed weekly performance of 18.72%. XOMA Corporation (NASDAQ:XOMA) announced its pivotal Phase 3 gevokizumab study in patients with active pyoderma gangrenosum (PG), a rare neutrophilic dermatosis of expanding necrotic skin ulcers, is open for patient enrollment. The objective of the study is to assess the efficacy and safety of gevokizumab in treating the active ulcers caused by this rare and debilitating disease. The FDA granted orphan drug designation to gevokizumab for PG in February 2014.Return on Investment for XOMA Corporation (NASDAQ:XOMA) is -157.30% and on Tuesday its shares closed at $4.18. XOMA Corporation (NASDAQ:XOMA) monthly performance stands at 3.72% while its year to date performance is -37.89%. Calamos Asset Management Inc. (NASDAQ:CLMS) announced a cash dividend. Payment of $0.15 per share is scheduled to be paid on November 20, 2014. Shareholders who purchased CLMS stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 20% increase over the same period a year ago. At the current stock price of $13.7, the dividend yield is 4.38%. Calamos Asset Management Inc. (NASDAQ:CLMS) shares moved down -0.51% on last trading day to close the day at $13.70. Company price to sale ratio is 1.09 and has 18.10% insider ownership. Calamos Asset Management Inc. (NASDAQ:CLMS) belongs to Financial sector. On 29 October Kraft Foods Group, Inc. (NASDAQ:KRFT) announced financial results for the third quarter of 2014. Organic Net Revenues increased 0.9 percent as pricing to offset significant rises in commodity costs contributed 2.1 percentage points of growth. On last trading day Kraft Foods Group, Inc. (NASDAQ:KRFT) moved up 0.58% to close at $57.12. KRFT is -4.76% away from its 52 week high and is moving 16.20% ahead of its 52 week low. Kraft Foods Group, Inc. (NASDAQ:KRFT) return on investment (ROI) is 21.20% while return on equity (ROE) is 46.40%. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced the initiation of a Phase III clinical trial in the U.S. evaluating a 72 mcg capsule of linaclotide to be taken once per day for the treatment of adults suffering from chronic idiopathic constipation (CIC). Linaclotide is currently approved by the U.S. Food and Drug Administration as a 145 mcg capsule to be taken once per day for the treatment of adults with CIC and as a 290 mcg capsule to be taken once per day for the treatment of adults with irritable bowel syndrome with constipation (IBS-C). Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) on Tuesday closed at $13.54. Stock insider ownership includes 0.40%. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) distance from 50-day simple moving average (SMA50) is 4.91%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
